Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13Neoplasms 8Breast Neoplasms 4Hypogonadism 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Fatigue 2Dyspareunia 2Arthralgia 2Vaginitis 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Osteoporosis 1Obesity 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hot Flashes 1Eunuchism 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Testosterone × Clear all
NCT00853697 2015-10-30

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
6 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡